FDA approved the first new kind of pain medication in 27 years. Here’s how it works
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
Losing your hair? Here are three common medications that can make things worse
In a previous column, I discussed some common medications that can cause or worsen dry skin. In this column, we’ll look at ...
pharmaphorum5d
Pfizer’s Litfulo becomes first NHS drug for alopecia areata
Analysts think that alopecia areata could represent a $1 ... pharmaphorum chats with SIFI CEO and Chairman Fabrizio Chines about a new treatment for acanthamoeba keratitis. Join the conversation ...
The American Journal of Managed Care2d
Unmet Needs for the Management of Alopecia Areata
Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments ...
Alopecia Treatment Market Size to Surpass USD 5.20 Billion by 2033 | Straits Research
The global alopecia treatment market size was valued at USD 3.48 billion in 2024 and is projected to reach from USD 3.62 billion in 2025 to USD 5.20 billion by 2033, growing at a CAGR of 4.1% during ...
dermatologyadvisor1d
Alopecia Areata Risk May be Associated With Serum Vitamin D and Zinc Levels
The risk for alopecia areata is increased among patients with lower serum levels of vitamin D and zinc, but no relationship was observed with copper.
Daily4d
Superficial cryotherapy effective as alternative treatment option for patchy alopecia areata: Study
Superficial cryotherapy is a novel cold-based treatment that has emerged as a potential therapy for patchy alopecia areata ...
The American Journal of Managed Care2d
Exploring Guidelines for Alopecia Areata
The chronicity of alopecia areata is linked to persistent immune dysregulation and genetic predisposition. Panelists discuss how the high failure rate of conventional treatments for long-standing ...